IL1B and inflammatory bowel disease: It is established that TNF‐α, IL‐6, and IL‐1β are key proinflammatory cytokines involved in the onset of colitis,27 and IL‐10, an anti‐inflammatory cytokine, increases following Res administration in IBD patients.28